Do you want to skip to content? Skip to content
България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾
False /oidc-signin/en-gb/ България България Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Österreich Österreich Schweiz (Deutsch) Schweiz (Deutsch) Deutschland Deutschland Ελλάδα Ελλάδα United Kingdom United Kingdom Ireland Ireland España España Eesti Eesti Suomi Suomi Suisse (Français) Suisse (Français) France France Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Italia Italia Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta Norge Norge België België Nederland Nederland Polska Polska Portugal Portugal România România Slovensko Slovensko Slovenija Slovenija Srbija Srbija Sverige Sverige Türkiye Türkiye Україна Україна Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق Australia Australia India India Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Indonesia Indonesia 日本 日本 대한민국 대한민국 ไทย ไทย Việt Nam Việt Nam 中国大陆 中国大陆 中国香港特别行政区 中国香港特别行政区 中国台湾 中国台湾

Hard-to-heal wounds

Infection and Biofilm Management

In the battle against hard-to-heal wounds, there is an invisible enemy, Biofilm.

MORE THAN SILVER™ technology

A major barrier to wound healing, biofilm is present in at least 78% of hard-to-heal wounds. 1
Thanks to our breakthrough MORE THAN SILVER™ technology - which contains ionic silver together with a surfactant and a metal chelating agent - our dressing delivers superior2 antibiofilm performance compared to other tested silver dressings.

Find out about MORE THAN SILVER™ technology

A Multinational Randomised Controlled Trial3

Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial3

Evidence shows Aquacel Ag+ Extra™ effectively disrupts and destroys biofilm4,5 with Aquacel® Ag+ Extra™ achieving superior complete wound closure vs DACC dressings in an RCT.3

Find out about the RCT

A Health Economic Publication6

Management of VLUs with Aquacel® Ag+Extra versus Cutimed® Sorbact® was associated with

✓ Higher rate of and shorter time to complete wound closure.
✓ Reduction in the total cost of leg ulcer management.
✓ Improvement in HRQoL.

Find out about the HE

NICE-published cost comparison

The NICE Late Stage Assessment includes a health economic analysis of infected leg ulcers using different types of antimicrobial agents. NICE reviewed cost-modelling shows Aquacel® Ag+ Extra™ saves >£500 per patient to treat an infected leg ulcer.⁷

Read more More about Aquacel® Ag+ Extra™

Our Infection and Biofilm Management Product Portfolio

Aquacel® Ag+ Extra™

Aquacel® Ag+ Extra™

AQUACEL® Ag Foam

AQUACEL® Ag Foam

AQUACEL® Ag Burn Hydrofiber® Dressing, Sterile

AQUACEL® Ag Burn Hydrofiber® Dressing, Sterile

AQUACEL® Ag SURGICAL cover dressing

AQUACEL® Ag SURGICAL cover dressing

Not all claims are supported in all regulatory geographies.

1. Malone M et al. 2017. The prevalence of biofilm in chronic wounds: a systematic review and meta-analysis of published data. JWC: 20-25.

2. Bowler PG, Parsons D. Combatting wound biofilm and recalcitrance with a novel anti-biofilm Hydrofiber® wound dressing. Wound Medicine 14 (2016) 6-11.

3. Beraldo S. et al. Effectiveness of an enhanced silver-containing dressing in hard-to-heal venous leg ulcers: a randomised controlled trial. Journal of Wound Care, 2025.

4. Meredith K, et al. Assessment of the Antibiofilm Performance of Silver-Containing Wound Dressings: A Dual-Species Biofilm Model. Cureus. 2024; 16(9):e70086.

5. Meredith et al. Assessment of Silver-Containing Gelling Fiber Dressings Against Antibiotic-Resistant Pathogens Using an in vitro Biofilm Model. Infect Drug Resist. 2023 Nov 2;16:7015-7019.

6. Guest, J. F. (2025). Cost-effectiveness of an enhanced silver-containing dressing in treating hard-to-heal venous leg ulcers. JWC. 34, 1-11.

AP-76093-GBL-ENG

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?